• Info
  • Significant Ownership

Significant Ownership of Dr. Reddy's Laboratories, Inc.

Signature - Title
/s/ Stephen Peterson - Vice President, Head of Finance NAG
Location
Princeton, NJ
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Dr. Reddy's Laboratories, Inc..

Notify me when Dr. Reddy's Laboratories, Inc. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Dr. Reddy's Laboratories, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
COYA Coya Therapeutics, Inc. Common Stock, $0.0001 par value per share 9.7% $10,727,271 2,272,727 Dr. Reddy's Laboratories, Inc. 30 Jan 2026

Schedules 13D/G Reported by Dr. Reddy's Laboratories, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.